• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地尔硫䓬对健康受试者血浆中地高辛水平及尿排泄的影响。

Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects.

作者信息

Yoshida A, Fujita M, Kurosawa N, Nioka M, Shichinohe T, Arakawa M, Fukuda R, Owada E, Ito K

出版信息

Clin Pharmacol Ther. 1984 May;35(5):681-5. doi: 10.1038/clpt.1984.95.

DOI:10.1038/clpt.1984.95
PMID:6713780
Abstract

To evaluate a possible effect of diltiazem hydrochloride (DTZ) on digoxin (DX) kinetics, we performed a study in which a single oral dose of DX (0.5 or 0.75 mg) was given with and without DTZ (30 mg three times daily for 1 wk) to six healthy subjects. DTZ increased plasma DX concentrations at 3, 4, 6, and 12 hr and decreased renal clearance of DX from 3.05 +/- 0.126 to 2.31 +/- 0.234 ml/min/kg. There was no significant change in absorption t 1/2, peak concentration, peak concentration time, distribution t 1/2, biologic elimination t 1/2, or apparent volume of distribution with DTZ.

摘要

为评估盐酸地尔硫䓬(DTZ)对地高辛(DX)动力学的可能影响,我们开展了一项研究,对6名健康受试者给予单次口服剂量的DX(0.5或0.75毫克),给药时分别联合及不联合DTZ(每日3次,每次30毫克,共1周)。DTZ使3、4、6和12小时时的血浆DX浓度升高,并使DX的肾脏清除率从3.05±0.126降至2.31±0.234毫升/分钟/千克。联合DTZ时,吸收半衰期、峰浓度、峰浓度时间、分布半衰期、生物消除半衰期或表观分布容积均无显著变化。

相似文献

1
Effects of diltiazem on plasma level and urinary excretion of digoxin in healthy subjects.地尔硫䓬对健康受试者血浆中地高辛水平及尿排泄的影响。
Clin Pharmacol Ther. 1984 May;35(5):681-5. doi: 10.1038/clpt.1984.95.
2
Effects of diltiazem on plasma and tissue digoxin levels in mice.地尔硫䓬对小鼠血浆和组织中地高辛水平的影响。
J Pharmacobiodyn. 1984 Aug;7(8):511-6. doi: 10.1248/bpb1978.7.511.
3
The diltiazem-digoxin interaction.地尔硫䓬-地高辛相互作用。
Clin Pharmacol Ther. 1984 Aug;36(2):183-9. doi: 10.1038/clpt.1984.160.
4
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.
Clin Pharmacol Ther. 1985 Feb;37(2):150-6. doi: 10.1038/clpt.1985.27.
5
The influence of diltiazem hydrochloride on trough serum digoxin concentrations.盐酸地尔硫䓬对血清地高辛谷浓度的影响。
Drug Intell Clin Pharm. 1986 Jun;20(6):500-3. doi: 10.1177/106002808602000615.
6
Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine.地尔硫䓬治疗会损害肝脏药物氧化:安替比林研究。
Clin Pharmacol Ther. 1986 Aug;40(2):140-3. doi: 10.1038/clpt.1986.152.
7
Digoxin-diltiazem interaction: a pharmacokinetic evaluation.地高辛与地尔硫䓬的相互作用:药代动力学评价。
Eur J Clin Pharmacol. 1986;31(3):351-3. doi: 10.1007/BF00981136.
8
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.地尔硫䓬与硝酸异山梨酯对慢性缺血性心力衰竭患者地高辛药效学和药代动力学影响的比较
Saudi Med J. 2002 Jun;23(6):725-31.
9
No increase in serum digoxin concentration with high-dose diltiazem.高剂量地尔硫䓬不会使血清地高辛浓度升高。
Am J Med. 1986 Sep;81(3):425-8. doi: 10.1016/0002-9343(86)90293-7.
10
Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration.
Eur J Drug Metab Pharmacokinet. 1991 Jan-Mar;16(1):69-74. doi: 10.1007/BF03189877.

引用本文的文献

1
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.伊曲康唑和地尔硫䓬对P-糖蛋白底物非索非那定药代动力学的影响。
Br J Clin Pharmacol. 2006 May;61(5):538-44. doi: 10.1111/j.1365-2125.2006.02613.x.
2
Cardiac glycosides. Drug interactions of clinical significance.强心苷。具有临床意义的药物相互作用。
Drug Saf. 1995 Feb;12(2):97-109. doi: 10.2165/00002018-199512020-00003.
3
Calcium antagonists. Drug interactions of clinical significance.钙拮抗剂。具有临床意义的药物相互作用。
Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003.
4
[Pharmacokinetic and cardiac efficacy of beta-acetyldigoxin and digitoxin in combination therapy with diltiazem].[β-乙酰地高辛和洋地黄毒苷与地尔硫䓬联合治疗的药代动力学及心脏疗效]
Klin Wochenschr. 1985 Jul 15;63(14):636-42. doi: 10.1007/BF01732859.
5
Diltiazem. A review of its pharmacological properties and therapeutic efficacy.地尔硫䓬。其药理特性与治疗效果综述。
Drugs. 1985 May;29(5):387-454. doi: 10.2165/00003495-198529050-00001.
6
Digoxin-diltiazem interaction: a pharmacokinetic evaluation.地高辛与地尔硫䓬的相互作用:药代动力学评价。
Eur J Clin Pharmacol. 1986;31(3):351-3. doi: 10.1007/BF00981136.
7
Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.地高辛肾小管分泌的临床药代动力学意义。
Clin Pharmacokinet. 1987 Nov;13(5):334-43. doi: 10.2165/00003088-198713050-00004.
8
Interaction between Ca2+ antagonists and digitalis.
Cardiovasc Drugs Ther. 1988 Jan;1(5):441-6. doi: 10.1007/BF02125729.
9
Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.地高辛与抗心律失常药物及钙通道阻滞剂之间的药代动力学药物相互作用:研究方法评估
Cardiovasc Drugs Ther. 1987 Aug;1(2):183-9. doi: 10.1007/BF02125472.
10
Digoxin-felodipine interaction in patients with congestive heart failure.充血性心力衰竭患者中地高辛与非洛地平的相互作用。
Eur J Clin Pharmacol. 1988;35(5):461-5. doi: 10.1007/BF00558239.